BD is a global leader in the medical devices industry with a commitment to advancing the world of health. The company has established a comprehensive ESG strategy with near-term and 2050 Net-Zero targets approved by the Science Based Targets initiative. BD's sustainability efforts encompass environmental, social, and governance issues, including access to healthcare and other social topics, with dedicated associates worldwide delivering measurable progress on ESG goals.
About C.R. Bard
- Status
- Unverified
- Website
- Visit Website
C.R. Bard Sustainability Actions
C.R. Bard Sustainability Commitments
2050
Net-Zero Emissions Target
BD has committed to achieving Net-Zero emissions by 2050 as part of its long-term climate strategy.
